Hepatitis/Hepatitis Exposure: Donor is deferred for 12 months after hepatitis B or hepatitis C exposure. Heart Attack: Further evaluation is needed.Gonorrhea: Donor is deferred for 3 months after date of last treatment.Dental Work: Donors are eligible to donate following routine dental work.Diabetes: Donors with diabetes (type I or II) are eligible to donate.COVID19- Donors are eligible 10 days after the resolution of symptoms OR a positive test if remained asymptomatic (no symptoms).Colds: Donors are not eligible if they are not feeling well and healthy the day of donation.There is a permanent deferral for donors with a history of: Carcinoma-in-situ or Dysplasia of the cervix or breast, if treated or completely removed and healed.There is no deferral period for donors with a history of: Cancer: Donors with a history of most types of cancer are eligible to donate 1 year from the date of their last treatment.Antibiotics: Donors are deferred for 24 hours after their final dose.Donors must weigh at least 110 pounds and no more than 350 poundsĬovid-19 and Flu vaccines and Boosters require NO WAITING period to donate as long as you are feeling well and healthy.Donors must be at least 17 years of age, or 16 with parental consent (PDF: 16-year-old parental consent form).Donors must be in good health and feel well the day of their donation.Donors must complete a questionnaire, which includes health and lifestyle questions, at their blood donation appointment to determine eligibility. THERE HAVE BEEN MANY CHANGES TO ELIGIBILITY!Īll blood donors must meet Massachusetts General Hospital’s eligibility requirements to donate whole blood, platelets or red blood cells. Once the new FDA recommendations are finalized, both the MGH Donor Center and the BWH/DFCI Kraft Family Blood Donor Center plan to implement them as soon as feasible. Instead of deferring men who have sex with men from donating for 3 months since their last sexual contact, the FDA is recommending assessing all donors using gender-inclusive screening questions intended to individualize the assessment of risk. The FDA announced a proposed change to its approach to reducing the risk of HIV transmission by blood transfusion. The Massachusetts General Hospital’s Blood Donor Program’s response to the FDA’s January 27, 2023, announced recommendations Billing, Insurance & Financial Assistance.
0 Comments
Leave a Reply. |